Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Awards Harvard Researcher $373K for Protein Research Using NMR

NEW YORK (GenomeWeb News) – Agilent Technologies and the Agilent Technologies Foundation announced today a three-year, nearly $373,000 award to Gerhard Wagner at Harvard Medical School for research into large proteins using nuclear magnetic resonance spectroscopy.

The Agilent Thought Leader Award will support Gerhard and his laboratory's research developing fast and efficient assignment methods for large proteins using high magnetic field NMR spectroscopy, and then making them accessible to the structural biology community, Agilent said.

The laboratory is affiliated with the department of biological chemistry and molecular pharmacology at HMS.

"NMR spectroscopy has still a tremendous potential to grow and provide unique information about important biological systems, such as large multidomain proteins, protein complexes, and membrane proteins," Wagner said in a statement. The award, he added, will be used to further innovations with the technology.

"This will provide tools for generating new insights into structures of large macromolecular complexes, understanding of biological mechanisms, and design of new drugs to fight human disease," he said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.